To include your compound in the COVID-19 Resource Center, submit it here.

Probuphine buprenorphine: Additional Phase III data

Additional data from a U.S. Phase III trial in 287 patients aged 18-60 with opioid dependence showed that 36% of patients treated with Probuphine had negative urine samples

Read the full 288 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE